

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of light stimulus involved in sensory perception (GO:0050962) | 9.37378211 |
| 2 | detection of light stimulus involved in visual perception (GO:0050908) | 9.37378211 |
| 3 | retinal rod cell development (GO:0046548) | 8.53788170 |
| 4 | response to pheromone (GO:0019236) | 7.71044586 |
| 5 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 7.11371582 |
| 6 | cellular potassium ion homeostasis (GO:0030007) | 6.33877504 |
| 7 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 6.08117573 |
| 8 | sodium ion export (GO:0071436) | 5.90959623 |
| 9 | relaxation of smooth muscle (GO:0044557) | 5.51779088 |
| 10 | positive regulation of synapse maturation (GO:0090129) | 5.38260894 |
| 11 | urinary tract smooth muscle contraction (GO:0014848) | 5.32399019 |
| 12 | potassium ion homeostasis (GO:0055075) | 5.20896291 |
| 13 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.83331155 |
| 14 | tachykinin receptor signaling pathway (GO:0007217) | 4.80296800 |
| 15 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.75740955 |
| 16 | keratinization (GO:0031424) | 4.64997888 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 4.59935300 |
| 18 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.57370521 |
| 19 | cardiac muscle contraction (GO:0060048) | 4.51562479 |
| 20 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.46717452 |
| 21 | glutamate secretion (GO:0014047) | 4.40061169 |
| 22 | synaptic vesicle maturation (GO:0016188) | 4.35123068 |
| 23 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.31848151 |
| 24 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.31583122 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.31146504 |
| 26 | somite rostral/caudal axis specification (GO:0032525) | 4.26314867 |
| 27 | regulation of actin filament-based movement (GO:1903115) | 4.21277580 |
| 28 | photoreceptor cell development (GO:0042461) | 4.16542739 |
| 29 | eye photoreceptor cell development (GO:0042462) | 4.13499469 |
| 30 | cardiac muscle hypertrophy (GO:0003300) | 4.05519924 |
| 31 | potassium ion export (GO:0071435) | 4.04383323 |
| 32 | cell communication by electrical coupling (GO:0010644) | 4.02619128 |
| 33 | regulation of synapse maturation (GO:0090128) | 3.97719052 |
| 34 | detection of calcium ion (GO:0005513) | 3.96196128 |
| 35 | retinal cone cell development (GO:0046549) | 3.94318915 |
| 36 | glycolytic process (GO:0006096) | 3.93839380 |
| 37 | neuronal ion channel clustering (GO:0045161) | 3.93589051 |
| 38 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.91739446 |
| 39 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.89817046 |
| 40 | cerebellar granule cell differentiation (GO:0021707) | 3.89215641 |
| 41 | regulation of cell communication by electrical coupling (GO:0010649) | 3.84787893 |
| 42 | potassium ion import (GO:0010107) | 3.82151734 |
| 43 | striated muscle hypertrophy (GO:0014897) | 3.81191917 |
| 44 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.79650550 |
| 45 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.78052556 |
| 46 | protein localization to synapse (GO:0035418) | 3.77111215 |
| 47 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.65647056 |
| 48 | sarcomere organization (GO:0045214) | 3.64213469 |
| 49 | synaptic vesicle endocytosis (GO:0048488) | 3.60284868 |
| 50 | muscle hypertrophy (GO:0014896) | 3.58478079 |
| 51 | calcium ion import (GO:0070509) | 3.56510741 |
| 52 | primitive streak formation (GO:0090009) | 3.55727583 |
| 53 | positive regulation of gastrulation (GO:2000543) | 3.54644542 |
| 54 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.52986636 |
| 55 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.50284446 |
| 56 | photoreceptor cell maintenance (GO:0045494) | 3.49830934 |
| 57 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.47002164 |
| 58 | cardiac conduction (GO:0061337) | 3.46175636 |
| 59 | membrane repolarization (GO:0086009) | 3.45007947 |
| 60 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.42401880 |
| 61 | muscle hypertrophy in response to stress (GO:0003299) | 3.42401880 |
| 62 | cardiac muscle adaptation (GO:0014887) | 3.42401880 |
| 63 | locomotory exploration behavior (GO:0035641) | 3.42235055 |
| 64 | innervation (GO:0060384) | 3.38988560 |
| 65 | sensory perception of light stimulus (GO:0050953) | 3.36274889 |
| 66 | regulation of relaxation of muscle (GO:1901077) | 3.36272332 |
| 67 | activation of protein kinase A activity (GO:0034199) | 3.36132944 |
| 68 | neurotransmitter secretion (GO:0007269) | 3.35478284 |
| 69 | visual perception (GO:0007601) | 3.34998576 |
| 70 | regulation of ARF protein signal transduction (GO:0032012) | 3.32178457 |
| 71 | rhodopsin mediated signaling pathway (GO:0016056) | 3.30722273 |
| 72 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.27162535 |
| 73 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.26030349 |
| 74 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.24400930 |
| 75 | muscle cell cellular homeostasis (GO:0046716) | 3.23231730 |
| 76 | striatum development (GO:0021756) | 3.21934576 |
| 77 | cell wall macromolecule metabolic process (GO:0044036) | 3.21687728 |
| 78 | cell wall macromolecule catabolic process (GO:0016998) | 3.21687728 |
| 79 | cellular sodium ion homeostasis (GO:0006883) | 3.17976775 |
| 80 | positive regulation of TOR signaling (GO:0032008) | 3.17520417 |
| 81 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.17394341 |
| 82 | regulation of cardioblast proliferation (GO:0003264) | 3.17394341 |
| 83 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.16443725 |
| 84 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.15302772 |
| 85 | peptide cross-linking (GO:0018149) | 3.13060290 |
| 86 | cardiac muscle cell action potential (GO:0086001) | 3.11599245 |
| 87 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.11074646 |
| 88 | cardiac myofibril assembly (GO:0055003) | 3.07094115 |
| 89 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.06798312 |
| 90 | positive regulation of sodium ion transport (GO:0010765) | 3.06622677 |
| 91 | detection of visible light (GO:0009584) | 3.04464037 |
| 92 | neuronal action potential propagation (GO:0019227) | 3.03972237 |
| 93 | endothelial cell chemotaxis (GO:0035767) | 3.03679396 |
| 94 | regulation of the force of heart contraction (GO:0002026) | 3.03266186 |
| 95 | protein-chromophore linkage (GO:0018298) | 3.02261618 |
| 96 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.00675959 |
| 97 | regulation of skeletal muscle contraction (GO:0014819) | 3.00348670 |
| 98 | detection of light stimulus (GO:0009583) | 3.00258081 |
| 99 | vocalization behavior (GO:0071625) | 2.99505518 |
| 100 | regulation of bile acid biosynthetic process (GO:0070857) | 2.97055528 |
| 101 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.97015300 |
| 102 | positive regulation of calcium ion import (GO:0090280) | 2.96507940 |
| 103 | relaxation of cardiac muscle (GO:0055119) | 2.95900679 |
| 104 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.95766381 |
| 105 | relaxation of muscle (GO:0090075) | 2.95157048 |
| 106 | positive regulation of vascular permeability (GO:0043117) | 2.94865834 |
| 107 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.93922816 |
| 108 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.92299707 |
| 109 | cGMP-mediated signaling (GO:0019934) | 2.92282015 |
| 110 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.91529622 |
| 111 | muscle organ morphogenesis (GO:0048644) | 2.91336780 |
| 112 | neuromuscular process controlling balance (GO:0050885) | 2.89906539 |
| 113 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.89678514 |
| 114 | import into cell (GO:0098657) | 2.89447242 |
| 115 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.89357142 |
| 116 | cell communication involved in cardiac conduction (GO:0086065) | 2.89000104 |
| 117 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.87052057 |
| 118 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.85542535 |
| 119 | polyketide metabolic process (GO:0030638) | 2.84892811 |
| 120 | doxorubicin metabolic process (GO:0044598) | 2.84892811 |
| 121 | daunorubicin metabolic process (GO:0044597) | 2.84892811 |
| 122 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.84642784 |
| 123 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.83813519 |
| 124 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.83143471 |
| 125 | muscle filament sliding (GO:0030049) | 2.82957840 |
| 126 | actin-myosin filament sliding (GO:0033275) | 2.82957840 |
| 127 | regulation of neurotransmitter secretion (GO:0046928) | 2.82936543 |
| 128 | retinoic acid receptor signaling pathway (GO:0048384) | 2.82509134 |
| 129 | cellular response to epinephrine stimulus (GO:0071872) | 2.82134742 |
| 130 | membrane depolarization during action potential (GO:0086010) | 2.81989935 |
| 131 | regulation of sarcomere organization (GO:0060297) | 2.81731123 |
| 132 | regulation of response to osmotic stress (GO:0047484) | 2.81371251 |
| 133 | central nervous system myelination (GO:0022010) | 2.81245171 |
| 134 | axon ensheathment in central nervous system (GO:0032291) | 2.81245171 |
| 135 | negative regulation of cell size (GO:0045792) | 2.80915712 |
| 136 | mating behavior (GO:0007617) | 2.79246359 |
| 137 | pyrimidine dimer repair (GO:0006290) | 2.78702201 |
| 138 | detection of temperature stimulus (GO:0016048) | 2.76305578 |
| 139 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.75507044 |
| 140 | myofibril assembly (GO:0030239) | 2.74980482 |
| 141 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.74595895 |
| 142 | skeletal muscle contraction (GO:0003009) | 2.74087392 |
| 143 | regulation of heart contraction (GO:0008016) | 2.73826921 |
| 144 | regulation of striated muscle contraction (GO:0006942) | 2.73766019 |
| 145 | long term synaptic depression (GO:0060292) | 2.73603713 |
| 146 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.73599731 |
| 147 | regulation of sodium ion transport (GO:0002028) | 2.73513060 |
| 148 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.73021221 |
| 149 | striated muscle contraction (GO:0006941) | 2.72109158 |
| 150 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.71761334 |
| 151 | iron ion import (GO:0097286) | 2.71001095 |
| 152 | regulation of cardiac muscle contraction (GO:0055117) | 2.70116033 |
| 153 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.70103237 |
| 154 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.69794288 |
| 155 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.69661331 |
| 156 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.68955990 |
| 157 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.68955990 |
| 158 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.67761946 |
| 159 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.65819608 |
| 160 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.65675768 |
| 161 | regulation of membrane repolarization (GO:0060306) | 2.65355605 |
| 162 | pyruvate metabolic process (GO:0006090) | 2.64380234 |
| 163 | neurotransmitter transport (GO:0006836) | 2.63712283 |
| 164 | maintenance of protein location in nucleus (GO:0051457) | 2.63572195 |
| 165 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.63401389 |
| 166 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.62925531 |
| 167 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.62925531 |
| 168 | actomyosin structure organization (GO:0031032) | 2.62119410 |
| 169 | muscle contraction (GO:0006936) | 2.61611262 |
| 170 | membrane hyperpolarization (GO:0060081) | 2.61601099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.62686892 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.48900311 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.36921292 |
| 4 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.24651231 |
| 5 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.84937971 |
| 6 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.51216705 |
| 7 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 2.49135870 |
| 8 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.49085978 |
| 9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.48405416 |
| 10 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.38258383 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.24677454 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13798895 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.08538139 |
| 14 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.04850348 |
| 15 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.98480828 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.96308257 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.90014923 |
| 18 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.86911965 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.85887588 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.83665294 |
| 21 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.83241303 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.82544706 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.79196831 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.78344189 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.78344189 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.77746431 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.77490404 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.77450690 |
| 29 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.73831220 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.71889004 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.70655914 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69557676 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.68343720 |
| 34 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.67806257 |
| 35 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.66991114 |
| 36 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.61150844 |
| 37 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.60289539 |
| 38 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.57016460 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.54466698 |
| 40 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.53063490 |
| 41 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.51843069 |
| 42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.51263961 |
| 43 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49758520 |
| 44 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.49306671 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47535772 |
| 46 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.47155247 |
| 47 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.47075573 |
| 48 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.47075573 |
| 49 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.47075573 |
| 50 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45074383 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.43276152 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41984555 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37927928 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37286409 |
| 55 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.37237867 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36837924 |
| 57 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.36494547 |
| 58 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.35495443 |
| 59 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.32613388 |
| 60 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.30870465 |
| 61 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29925771 |
| 62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28884442 |
| 63 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27902525 |
| 64 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27758299 |
| 65 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.27385687 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.26522226 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26083357 |
| 68 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.24462710 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24219638 |
| 70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23796692 |
| 71 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23191400 |
| 72 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.22972221 |
| 73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.22956782 |
| 74 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22925221 |
| 75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22395697 |
| 76 | AR_19668381_ChIP-Seq_PC3_Human | 1.21694754 |
| 77 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.19622563 |
| 78 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.17611671 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17404800 |
| 80 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17265848 |
| 81 | * P68_20966046_ChIP-Seq_HELA_Human | 1.16234391 |
| 82 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.15965429 |
| 83 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.15357333 |
| 84 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15220565 |
| 85 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14912900 |
| 86 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.14873610 |
| 87 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.14738101 |
| 88 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.13373259 |
| 89 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.11600682 |
| 90 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11089340 |
| 91 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.10649881 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09712812 |
| 93 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09615797 |
| 94 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.08061187 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06719722 |
| 96 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.06695918 |
| 97 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06129595 |
| 98 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05808248 |
| 99 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04708428 |
| 100 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03508412 |
| 101 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03205354 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02795202 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02469325 |
| 104 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02441077 |
| 105 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02002579 |
| 106 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01805944 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00857953 |
| 108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98857573 |
| 109 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97769756 |
| 110 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97769756 |
| 111 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.97642304 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97611510 |
| 113 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97360831 |
| 114 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.97189395 |
| 115 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96103803 |
| 116 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.96036082 |
| 117 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95396150 |
| 118 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.95335266 |
| 119 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94876377 |
| 120 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94839012 |
| 121 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94396583 |
| 122 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.93773108 |
| 123 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93397843 |
| 124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91988541 |
| 125 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91927879 |
| 126 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.91406273 |
| 127 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91189245 |
| 128 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.89628116 |
| 129 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.89615706 |
| 130 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.89381011 |
| 131 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89013114 |
| 132 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.88850595 |
| 133 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88603933 |
| 134 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87541688 |
| 135 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87537054 |
| 136 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87314616 |
| 137 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85254583 |
| 138 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.84623713 |
| 139 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82563091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 5.41719948 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.00995924 |
| 3 | MP0002090_abnormal_vision | 3.97608168 |
| 4 | MP0005423_abnormal_somatic_nervous | 3.59961242 |
| 5 | MP0006292_abnormal_olfactory_placode | 3.49961813 |
| 6 | MP0006072_abnormal_retinal_apoptosis | 3.45178399 |
| 7 | MP0002234_abnormal_pharynx_morphology | 3.37556700 |
| 8 | MP0004084_abnormal_cardiac_muscle | 3.32033779 |
| 9 | MP0003011_delayed_dark_adaptation | 3.14248467 |
| 10 | MP0004510_myositis | 2.96841371 |
| 11 | MP0000751_myopathy | 2.91598489 |
| 12 | MP0004233_abnormal_muscle_weight | 2.82092253 |
| 13 | MP0004036_abnormal_muscle_relaxation | 2.81572545 |
| 14 | MP0005253_abnormal_eye_physiology | 2.70011910 |
| 15 | MP0003880_abnormal_central_pattern | 2.67587094 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.65862093 |
| 17 | MP0003646_muscle_fatigue | 2.55849275 |
| 18 | MP0000749_muscle_degeneration | 2.55350587 |
| 19 | MP0001984_abnormal_olfaction | 2.32376691 |
| 20 | MP0003950_abnormal_plasma_membrane | 2.32075551 |
| 21 | MP0002332_abnormal_exercise_endurance | 2.29876572 |
| 22 | MP0001968_abnormal_touch/_nociception | 2.29011750 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.27294913 |
| 24 | MP0005248_abnormal_Harderian_gland | 2.21898084 |
| 25 | MP0008775_abnormal_heart_ventricle | 2.19994531 |
| 26 | MP0004215_abnormal_myocardial_fiber | 2.19698927 |
| 27 | MP0003879_abnormal_hair_cell | 2.18639286 |
| 28 | MP0009745_abnormal_behavioral_response | 2.17866533 |
| 29 | MP0001501_abnormal_sleep_pattern | 2.15278210 |
| 30 | MP0005167_abnormal_blood-brain_barrier | 2.14148930 |
| 31 | MP0005394_taste/olfaction_phenotype | 2.12183377 |
| 32 | MP0005499_abnormal_olfactory_system | 2.12183377 |
| 33 | MP0005195_abnormal_posterior_eye | 2.10451450 |
| 34 | MP0002063_abnormal_learning/memory/cond | 2.08615671 |
| 35 | MP0002909_abnormal_adrenal_gland | 2.00608102 |
| 36 | MP0004484_altered_response_of | 1.90542693 |
| 37 | MP0001502_abnormal_circadian_rhythm | 1.89062091 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.86449134 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.78321825 |
| 40 | MP0004145_abnormal_muscle_electrophysio | 1.77214668 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.77024006 |
| 42 | MP0010386_abnormal_urinary_bladder | 1.73444913 |
| 43 | MP0008789_abnormal_olfactory_epithelium | 1.68054059 |
| 44 | MP0000759_abnormal_skeletal_muscle | 1.65608898 |
| 45 | MP0002736_abnormal_nociception_after | 1.65437174 |
| 46 | MP0002572_abnormal_emotion/affect_behav | 1.59194775 |
| 47 | MP0001346_abnormal_lacrimal_gland | 1.57090782 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.56819784 |
| 49 | MP0003045_fibrosis | 1.56680753 |
| 50 | MP0005670_abnormal_white_adipose | 1.56480455 |
| 51 | MP0002269_muscular_atrophy | 1.55287936 |
| 52 | MP0004087_abnormal_muscle_fiber | 1.54831582 |
| 53 | MP0000537_abnormal_urethra_morphology | 1.54055628 |
| 54 | MP0005620_abnormal_muscle_contractility | 1.52585792 |
| 55 | MP0003890_abnormal_embryonic-extraembry | 1.49247527 |
| 56 | MP0000762_abnormal_tongue_morphology | 1.48149505 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.44976885 |
| 58 | MP0006138_congestive_heart_failure | 1.41974774 |
| 59 | MP0001970_abnormal_pain_threshold | 1.41013265 |
| 60 | MP0003137_abnormal_impulse_conducting | 1.38374446 |
| 61 | MP0002106_abnormal_muscle_physiology | 1.36753203 |
| 62 | MP0008961_abnormal_basal_metabolism | 1.36007071 |
| 63 | MP0002127_abnormal_cardiovascular_syste | 1.34279594 |
| 64 | MP0001324_abnormal_eye_pigmentation | 1.32353660 |
| 65 | MP0005391_vision/eye_phenotype | 1.31901629 |
| 66 | MP0003633_abnormal_nervous_system | 1.29514945 |
| 67 | MP0000920_abnormal_myelination | 1.26427694 |
| 68 | MP0005385_cardiovascular_system_phenoty | 1.26349181 |
| 69 | MP0001544_abnormal_cardiovascular_syste | 1.26349181 |
| 70 | MP0005330_cardiomyopathy | 1.26185112 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 1.24629791 |
| 72 | MP0000747_muscle_weakness | 1.24551885 |
| 73 | MP0002108_abnormal_muscle_morphology | 1.22186367 |
| 74 | MP0002653_abnormal_ependyma_morphology | 1.22103679 |
| 75 | MP0002752_abnormal_somatic_nervous | 1.21112281 |
| 76 | MP0005369_muscle_phenotype | 1.20538812 |
| 77 | MP0003329_amyloid_beta_deposits | 1.19885018 |
| 78 | MP0002733_abnormal_thermal_nociception | 1.19077846 |
| 79 | MP0001664_abnormal_digestion | 1.17932307 |
| 80 | MP0001348_abnormal_lacrimal_gland | 1.16530520 |
| 81 | MP0002972_abnormal_cardiac_muscle | 1.11596121 |
| 82 | MP0000678_abnormal_parathyroid_gland | 1.10216059 |
| 83 | MP0002229_neurodegeneration | 1.10033114 |
| 84 | MP0003631_nervous_system_phenotype | 1.09155042 |
| 85 | MP0003690_abnormal_glial_cell | 1.08704257 |
| 86 | MP0008004_abnormal_stomach_pH | 1.04702639 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 1.04110206 |
| 88 | MP0005623_abnormal_meninges_morphology | 1.04046313 |
| 89 | MP0005409_darkened_coat_color | 1.03409566 |
| 90 | MP0001756_abnormal_urination | 1.02906055 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 1.02657395 |
| 92 | MP0005386_behavior/neurological_phenoty | 1.01449593 |
| 93 | MP0004924_abnormal_behavior | 1.01449593 |
| 94 | MP0002066_abnormal_motor_capabilities/c | 1.01262198 |
| 95 | MP0009697_abnormal_copulation | 1.00177702 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.99277539 |
| 97 | MP0004811_abnormal_neuron_physiology | 0.98751221 |
| 98 | MP0004085_abnormal_heartbeat | 0.98164338 |
| 99 | MP0003315_abnormal_perineum_morphology | 0.96713478 |
| 100 | MP0000733_abnormal_muscle_development | 0.96373336 |
| 101 | MP0005666_abnormal_adipose_tissue | 0.95838264 |
| 102 | MP0002184_abnormal_innervation | 0.95780344 |
| 103 | MP0002557_abnormal_social/conspecific_i | 0.95633320 |
| 104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95124938 |
| 105 | MP0001486_abnormal_startle_reflex | 0.92933336 |
| 106 | MP0000230_abnormal_systemic_arterial | 0.91864907 |
| 107 | MP0002734_abnormal_mechanical_nocicepti | 0.88343205 |
| 108 | MP0004858_abnormal_nervous_system | 0.87726741 |
| 109 | MP0001440_abnormal_grooming_behavior | 0.87351386 |
| 110 | MP0002822_catalepsy | 0.85497003 |
| 111 | MP0008874_decreased_physiological_sensi | 0.84407769 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.81711127 |
| 113 | MP0002067_abnormal_sensory_capabilities | 0.78541231 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.76913441 |
| 115 | MP0000538_abnormal_urinary_bladder | 0.76061837 |
| 116 | MP0009046_muscle_twitch | 0.74031405 |
| 117 | MP0002933_joint_inflammation | 0.73688363 |
| 118 | MP0002882_abnormal_neuron_morphology | 0.73432164 |
| 119 | MP0010630_abnormal_cardiac_muscle | 0.73031222 |
| 120 | MP0003634_abnormal_glial_cell | 0.72246449 |
| 121 | MP0001986_abnormal_taste_sensitivity | 0.72101189 |
| 122 | MP0003279_aneurysm | 0.70392018 |
| 123 | MP0003632_abnormal_nervous_system | 0.70326514 |
| 124 | MP0001270_distended_abdomen | 0.70225389 |
| 125 | MP0005375_adipose_tissue_phenotype | 0.69456371 |
| 126 | MP0005266_abnormal_metabolism | 0.69284353 |
| 127 | MP0008569_lethality_at_weaning | 0.68366706 |
| 128 | MP0003635_abnormal_synaptic_transmissio | 0.68072422 |
| 129 | MP0005275_abnormal_skin_tensile | 0.67797276 |
| 130 | MP0003935_abnormal_craniofacial_develop | 0.67606354 |
| 131 | MP0000428_abnormal_craniofacial_morphol | 0.67419239 |
| 132 | MP0002064_seizures | 0.66162440 |
| 133 | MP0000013_abnormal_adipose_tissue | 0.66127600 |
| 134 | MP0004130_abnormal_muscle_cell | 0.66013198 |
| 135 | MP0002272_abnormal_nervous_system | 0.64987388 |
| 136 | MP0000631_abnormal_neuroendocrine_gland | 0.64458720 |
| 137 | MP0005535_abnormal_body_temperature | 0.64172835 |
| 138 | MP0003828_pulmonary_edema | 0.63631018 |
| 139 | MP0000955_abnormal_spinal_cord | 0.63604742 |
| 140 | MP0002089_abnormal_postnatal_growth/wei | 0.62795356 |
| 141 | MP0001188_hyperpigmentation | 0.62203020 |
| 142 | MP0001177_atelectasis | 0.61891817 |
| 143 | MP0004270_analgesia | 0.60761548 |
| 144 | MP0002932_abnormal_joint_morphology | 0.60045793 |
| 145 | MP0005595_abnormal_vascular_smooth | 0.59919622 |
| 146 | MP0002277_abnormal_respiratory_mucosa | 0.59844208 |
| 147 | MP0002638_abnormal_pupillary_reflex | 0.59634353 |
| 148 | MP0002233_abnormal_nose_morphology | 0.59414109 |
| 149 | MP0003755_abnormal_palate_morphology | 0.58656276 |
| 150 | MP0003183_abnormal_peptide_metabolism | 0.58515686 |
| 151 | MP0004043_abnormal_pH_regulation | 0.58214344 |
| 152 | MP0000534_abnormal_ureter_morphology | 0.58078446 |
| 153 | MP0001293_anophthalmia | 0.56109808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Central scotoma (HP:0000603) | 6.69695744 |
| 2 | Bundle branch block (HP:0011710) | 6.33714644 |
| 3 | Myokymia (HP:0002411) | 6.05218499 |
| 4 | Severe visual impairment (HP:0001141) | 5.50221124 |
| 5 | Abnormality of macular pigmentation (HP:0008002) | 5.48022729 |
| 6 | Scotoma (HP:0000575) | 5.22691511 |
| 7 | Sudden death (HP:0001699) | 5.18712506 |
| 8 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.70967501 |
| 9 | Heart block (HP:0012722) | 4.47258286 |
| 10 | Decreased central vision (HP:0007663) | 4.32129924 |
| 11 | Abnormal atrioventricular conduction (HP:0005150) | 4.26660643 |
| 12 | Pendular nystagmus (HP:0012043) | 4.02923779 |
| 13 | Aortic aneurysm (HP:0004942) | 3.92166477 |
| 14 | Exercise-induced myalgia (HP:0003738) | 3.91470351 |
| 15 | Atrioventricular block (HP:0001678) | 3.90725866 |
| 16 | Septo-optic dysplasia (HP:0100842) | 3.88088838 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 3.80575120 |
| 18 | Obstructive sleep apnea (HP:0002870) | 3.78466175 |
| 19 | Atonic seizures (HP:0010819) | 3.77653784 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 3.70671820 |
| 21 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.70590656 |
| 22 | Focal motor seizures (HP:0011153) | 3.59892644 |
| 23 | Papilledema (HP:0001085) | 3.59119806 |
| 24 | Postural instability (HP:0002172) | 3.54348244 |
| 25 | Dysmetric saccades (HP:0000641) | 3.42152700 |
| 26 | Focal seizures (HP:0007359) | 3.35094774 |
| 27 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.33988249 |
| 28 | Hypoplasia of the fovea (HP:0007750) | 3.33988249 |
| 29 | Increased connective tissue (HP:0009025) | 3.27744453 |
| 30 | Resting tremor (HP:0002322) | 3.21829066 |
| 31 | Ankle clonus (HP:0011448) | 3.21496221 |
| 32 | Keratoconus (HP:0000563) | 3.19763078 |
| 33 | Increased corneal curvature (HP:0100692) | 3.19763078 |
| 34 | Oral leukoplakia (HP:0002745) | 3.18693233 |
| 35 | Ventricular arrhythmia (HP:0004308) | 3.17729003 |
| 36 | Ventricular tachycardia (HP:0004756) | 3.10700185 |
| 37 | Action tremor (HP:0002345) | 3.07573491 |
| 38 | Type 1 muscle fiber predominance (HP:0003803) | 3.06256129 |
| 39 | Epileptic encephalopathy (HP:0200134) | 3.05521636 |
| 40 | Progressive cerebellar ataxia (HP:0002073) | 3.01302352 |
| 41 | Increased variability in muscle fiber diameter (HP:0003557) | 2.97927787 |
| 42 | Hypoplastic ischia (HP:0003175) | 2.97485694 |
| 43 | Difficulty running (HP:0009046) | 2.94763645 |
| 44 | Febrile seizures (HP:0002373) | 2.92880036 |
| 45 | Neoplasm of the heart (HP:0100544) | 2.87741679 |
| 46 | Round ear (HP:0100830) | 2.85501506 |
| 47 | Distal lower limb muscle weakness (HP:0009053) | 2.83789525 |
| 48 | Annular pancreas (HP:0001734) | 2.80097593 |
| 49 | Supranuclear gaze palsy (HP:0000605) | 2.77143650 |
| 50 | Ulnar deviation of the wrist (HP:0003049) | 2.73641969 |
| 51 | EMG: myopathic abnormalities (HP:0003458) | 2.72375784 |
| 52 | Myoglobinuria (HP:0002913) | 2.72189122 |
| 53 | Truncal ataxia (HP:0002078) | 2.71810683 |
| 54 | Abnormality of binocular vision (HP:0011514) | 2.71363815 |
| 55 | Diplopia (HP:0000651) | 2.71363815 |
| 56 | Foot dorsiflexor weakness (HP:0009027) | 2.69842858 |
| 57 | Abnormal gallbladder physiology (HP:0012438) | 2.66380526 |
| 58 | Cholecystitis (HP:0001082) | 2.66380526 |
| 59 | Dilated cardiomyopathy (HP:0001644) | 2.66246496 |
| 60 | Lipoatrophy (HP:0100578) | 2.65511735 |
| 61 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.63409196 |
| 62 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.63256221 |
| 63 | Dyschromatopsia (HP:0007641) | 2.61941655 |
| 64 | Abnormality of the fovea (HP:0000493) | 2.60842207 |
| 65 | Cone-rod dystrophy (HP:0000548) | 2.60816415 |
| 66 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.57443193 |
| 67 | Muscle fiber inclusion bodies (HP:0100299) | 2.56120119 |
| 68 | Cerebral hypomyelination (HP:0006808) | 2.52885036 |
| 69 | Abnormality of the calf musculature (HP:0001430) | 2.52691273 |
| 70 | Abdominal situs inversus (HP:0003363) | 2.50887633 |
| 71 | Abnormality of abdominal situs (HP:0011620) | 2.50887633 |
| 72 | Abnormality of the foot musculature (HP:0001436) | 2.49907819 |
| 73 | Muscle fiber splitting (HP:0003555) | 2.49794500 |
| 74 | Abnormality of the ischium (HP:0003174) | 2.48627185 |
| 75 | Atrial fibrillation (HP:0005110) | 2.48491971 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 2.48378130 |
| 77 | Vitreoretinal degeneration (HP:0000655) | 2.47076990 |
| 78 | EMG: neuropathic changes (HP:0003445) | 2.45669245 |
| 79 | Ependymoma (HP:0002888) | 2.43774713 |
| 80 | Prolonged QT interval (HP:0001657) | 2.43527850 |
| 81 | Dysmetria (HP:0001310) | 2.42759316 |
| 82 | Gaze-evoked nystagmus (HP:0000640) | 2.42105983 |
| 83 | Anxiety (HP:0000739) | 2.37373964 |
| 84 | Bradycardia (HP:0001662) | 2.32623357 |
| 85 | Clumsiness (HP:0002312) | 2.31032769 |
| 86 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.29133016 |
| 87 | Myopathic facies (HP:0002058) | 2.28667472 |
| 88 | Hepatoblastoma (HP:0002884) | 2.28638499 |
| 89 | Primary atrial arrhythmia (HP:0001692) | 2.26854835 |
| 90 | Calf muscle hypertrophy (HP:0008981) | 2.25851533 |
| 91 | Severe Myopia (HP:0011003) | 2.25474152 |
| 92 | Distal arthrogryposis (HP:0005684) | 2.25154804 |
| 93 | Bronchomalacia (HP:0002780) | 2.22453433 |
| 94 | Abnormality of the lower motor neuron (HP:0002366) | 2.21799953 |
| 95 | Neurofibrillary tangles (HP:0002185) | 2.19922338 |
| 96 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18923443 |
| 97 | Supraventricular tachycardia (HP:0004755) | 2.18457705 |
| 98 | Posterior subcapsular cataract (HP:0007787) | 2.17299394 |
| 99 | Spastic gait (HP:0002064) | 2.17289290 |
| 100 | Hyporeflexia of lower limbs (HP:0002600) | 2.16969179 |
| 101 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.15587318 |
| 102 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.15146211 |
| 103 | Hip contracture (HP:0003273) | 2.14987128 |
| 104 | Genetic anticipation (HP:0003743) | 2.14184472 |
| 105 | Cerebral aneurysm (HP:0004944) | 2.13804052 |
| 106 | Impaired smooth pursuit (HP:0007772) | 2.13638551 |
| 107 | Cupped ribs (HP:0000887) | 2.12386826 |
| 108 | Bulbar palsy (HP:0001283) | 2.12287389 |
| 109 | Depression (HP:0000716) | 2.11435875 |
| 110 | Fetal akinesia sequence (HP:0001989) | 2.10714213 |
| 111 | Supraventricular arrhythmia (HP:0005115) | 2.10435984 |
| 112 | Muscle stiffness (HP:0003552) | 2.10379496 |
| 113 | Nemaline bodies (HP:0003798) | 2.10170511 |
| 114 | Abnormality of the pubic bones (HP:0003172) | 2.09280129 |
| 115 | Hemiplegia (HP:0002301) | 2.09098425 |
| 116 | Waddling gait (HP:0002515) | 2.06612395 |
| 117 | Difficulty climbing stairs (HP:0003551) | 2.06550333 |
| 118 | Generalized tonic-clonic seizures (HP:0002069) | 2.05963129 |
| 119 | Poor eye contact (HP:0000817) | 2.05661669 |
| 120 | Frequent falls (HP:0002359) | 2.05650265 |
| 121 | Photophobia (HP:0000613) | 2.05582070 |
| 122 | Irregular epiphyses (HP:0010582) | 2.05339143 |
| 123 | Amelogenesis imperfecta (HP:0000705) | 2.05243099 |
| 124 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.05118459 |
| 125 | Areflexia of lower limbs (HP:0002522) | 2.05080491 |
| 126 | Ventricular fibrillation (HP:0001663) | 2.04005054 |
| 127 | Absence seizures (HP:0002121) | 2.03301829 |
| 128 | Tetraplegia (HP:0002445) | 2.00755014 |
| 129 | Scapular winging (HP:0003691) | 2.00250693 |
| 130 | Urinary urgency (HP:0000012) | 2.00162574 |
| 131 | Congenital stationary night blindness (HP:0007642) | 13.3738480 |
| 132 | Unsteady gait (HP:0002317) | 1.97857742 |
| 133 | Abolished electroretinogram (ERG) (HP:0000550) | 1.97280603 |
| 134 | Steppage gait (HP:0003376) | 1.96742475 |
| 135 | Abnormality of the astrocytes (HP:0100707) | 1.95212047 |
| 136 | Astrocytoma (HP:0009592) | 1.95212047 |
| 137 | Aplasia of the musculature (HP:0100854) | 1.94996742 |
| 138 | Sudden cardiac death (HP:0001645) | 1.92003725 |
| 139 | Chorioretinal atrophy (HP:0000533) | 1.91953522 |
| 140 | Rapidly progressive (HP:0003678) | 1.90577070 |
| 141 | Type II diabetes mellitus (HP:0005978) | 1.90525298 |
| 142 | Aneurysm (HP:0002617) | 1.90391796 |
| 143 | Albinism (HP:0001022) | 1.89975442 |
| 144 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.89390622 |
| 145 | Stereotypic behavior (HP:0000733) | 1.89205146 |
| 146 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.89179177 |
| 147 | Limited hip movement (HP:0008800) | 1.87519078 |
| 148 | Rimmed vacuoles (HP:0003805) | 1.87399295 |
| 149 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.86898655 |
| 150 | Lower limb muscle weakness (HP:0007340) | 1.86747214 |
| 151 | Pigmentary retinal degeneration (HP:0001146) | 1.86126227 |
| 152 | Partial duplication of thumb phalanx (HP:0009944) | 1.86023600 |
| 153 | Bradykinesia (HP:0002067) | 1.85845210 |
| 154 | Aortic dissection (HP:0002647) | 1.85386425 |
| 155 | Horizontal nystagmus (HP:0000666) | 1.83981958 |
| 156 | Mesomelia (HP:0003027) | 1.82930692 |
| 157 | Attenuation of retinal blood vessels (HP:0007843) | 1.82665576 |
| 158 | Visual hallucinations (HP:0002367) | 1.82347785 |
| 159 | Cerebral inclusion bodies (HP:0100314) | 1.82235092 |
| 160 | Absent septum pellucidum (HP:0001331) | 1.82025664 |
| 161 | Cholelithiasis (HP:0001081) | 1.81861501 |
| 162 | Lower limb amyotrophy (HP:0007210) | 1.81258024 |
| 163 | Slow progression (HP:0003677) | 1.80029653 |
| 164 | Bilateral microphthalmos (HP:0007633) | 1.76861600 |
| 165 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.73980062 |
| 166 | Constricted visual fields (HP:0001133) | 1.72827289 |
| 167 | Epiphyseal dysplasia (HP:0002656) | 1.72145741 |
| 168 | Dialeptic seizures (HP:0011146) | 1.71401319 |
| 169 | Limb-girdle muscle atrophy (HP:0003797) | 1.69405540 |
| 170 | Abnormal EKG (HP:0003115) | 1.69263496 |
| 171 | Hemiparesis (HP:0001269) | 1.69073580 |
| 172 | Distal lower limb amyotrophy (HP:0008944) | 1.66160737 |
| 173 | Syncope (HP:0001279) | 1.65669777 |
| 174 | Dysdiadochokinesis (HP:0002075) | 1.65103422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 4.57894860 |
| 2 | TTN | 3.99603312 |
| 3 | NEK1 | 3.92291819 |
| 4 | CDK12 | 3.48855747 |
| 5 | EPHA3 | 3.22270197 |
| 6 | PBK | 2.92310668 |
| 7 | TAOK2 | 2.84150625 |
| 8 | DAPK2 | 2.81853878 |
| 9 | PRPF4B | 2.65780362 |
| 10 | RIPK1 | 2.64701047 |
| 11 | STK38L | 2.61334602 |
| 12 | EEF2K | 2.54360777 |
| 13 | PHKG1 | 2.52241685 |
| 14 | PHKG2 | 2.52241685 |
| 15 | GRK5 | 2.28534111 |
| 16 | GRK1 | 2.12973086 |
| 17 | SGK494 | 2.05887659 |
| 18 | SGK223 | 2.05887659 |
| 19 | NTRK3 | 2.04270613 |
| 20 | MAP3K7 | 2.03389963 |
| 21 | ERN1 | 1.80539442 |
| 22 | STK38 | 1.76896946 |
| 23 | UHMK1 | 1.72878472 |
| 24 | TRIB3 | 1.69122654 |
| 25 | SGK2 | 1.68835852 |
| 26 | TNK2 | 1.67077810 |
| 27 | DYRK1A | 1.65548520 |
| 28 | PAK6 | 1.61190783 |
| 29 | CAMKK1 | 1.58733604 |
| 30 | NME1 | 1.57616706 |
| 31 | EPHA4 | 1.50714893 |
| 32 | GRK6 | 1.43278092 |
| 33 | MOS | 1.43124098 |
| 34 | PRKG2 | 1.40930888 |
| 35 | LATS2 | 1.39017677 |
| 36 | PINK1 | 1.31316944 |
| 37 | MAPKAPK3 | 1.31254482 |
| 38 | SGK3 | 1.29835631 |
| 39 | MAPK7 | 1.28863580 |
| 40 | ARAF | 1.28442218 |
| 41 | FER | 1.27782347 |
| 42 | MARK2 | 1.26843889 |
| 43 | PKN2 | 1.25463727 |
| 44 | DAPK3 | 1.23574151 |
| 45 | MAP3K4 | 1.22430796 |
| 46 | NTRK2 | 1.22208757 |
| 47 | OBSCN | 1.18923270 |
| 48 | DDR2 | 1.12132968 |
| 49 | PRKD3 | 1.11516061 |
| 50 | TGFBR2 | 1.10991407 |
| 51 | MAPK12 | 1.08657382 |
| 52 | MARK3 | 1.07460409 |
| 53 | PAK2 | 1.07351699 |
| 54 | PRKD2 | 1.06919570 |
| 55 | ADRBK2 | 1.03956845 |
| 56 | LMTK2 | 1.03380414 |
| 57 | HIPK2 | 0.98346023 |
| 58 | KSR2 | 0.97984485 |
| 59 | CSF1R | 0.97293052 |
| 60 | PIK3CG | 0.96557879 |
| 61 | CDK5 | 0.93300759 |
| 62 | SIK2 | 0.90627149 |
| 63 | INSRR | 0.90506373 |
| 64 | PRKAA1 | 0.90239420 |
| 65 | LATS1 | 0.90035406 |
| 66 | CAMK4 | 0.89955715 |
| 67 | FGFR3 | 0.87331407 |
| 68 | PAK3 | 0.87264421 |
| 69 | PDPK1 | 0.84070265 |
| 70 | MAP2K4 | 0.83009268 |
| 71 | TAOK1 | 0.80219662 |
| 72 | BMX | 0.77333053 |
| 73 | SIK1 | 0.76748559 |
| 74 | MAP3K10 | 0.75788436 |
| 75 | MINK1 | 0.75126243 |
| 76 | AKT2 | 0.75042353 |
| 77 | CAMK2G | 0.74591843 |
| 78 | DYRK1B | 0.74421470 |
| 79 | SGK1 | 0.73680870 |
| 80 | WNK1 | 0.69137771 |
| 81 | CDK14 | 0.68900125 |
| 82 | ICK | 0.68871078 |
| 83 | CAMK2B | 0.68456008 |
| 84 | PTK2 | 0.66687477 |
| 85 | MAP3K13 | 0.66612391 |
| 86 | EPHB1 | 0.66449088 |
| 87 | FES | 0.65804145 |
| 88 | CAMK2D | 0.65508250 |
| 89 | MAPK15 | 0.64655611 |
| 90 | MAPK13 | 0.64018345 |
| 91 | NEK6 | 0.61982048 |
| 92 | RPS6KA2 | 0.61790257 |
| 93 | TRPM7 | 0.61452068 |
| 94 | PKN1 | 0.61085062 |
| 95 | MAP3K1 | 0.59245461 |
| 96 | ADRBK1 | 0.59164975 |
| 97 | CAMK1 | 0.58910736 |
| 98 | FGFR4 | 0.56091381 |
| 99 | CDK15 | 0.56041346 |
| 100 | MARK1 | 0.56025632 |
| 101 | ROCK2 | 0.55397489 |
| 102 | PRKD1 | 0.55285775 |
| 103 | PRKAA2 | 0.53686101 |
| 104 | RET | 0.53278952 |
| 105 | DMPK | 0.53107846 |
| 106 | PRKCH | 0.52956505 |
| 107 | MAP3K5 | 0.51982222 |
| 108 | STK11 | 0.50131800 |
| 109 | MTOR | 0.49700449 |
| 110 | GRK7 | 0.49300918 |
| 111 | CAMKK2 | 0.48929890 |
| 112 | CDK11A | 0.48851920 |
| 113 | CDK18 | 0.48360383 |
| 114 | MAP3K6 | 0.48119131 |
| 115 | FGFR1 | 0.47860632 |
| 116 | TYRO3 | 0.47360638 |
| 117 | MUSK | 0.47011721 |
| 118 | ERBB2 | 0.45975953 |
| 119 | CDK8 | 0.45520238 |
| 120 | MAPK10 | 0.44183490 |
| 121 | IRAK2 | 0.42120505 |
| 122 | ROCK1 | 0.42095570 |
| 123 | RPS6KB1 | 0.42049005 |
| 124 | DAPK1 | 0.41039541 |
| 125 | PRKG1 | 0.40962013 |
| 126 | RPS6KA3 | 0.40011362 |
| 127 | BRAF | 0.39864461 |
| 128 | CAMK1D | 0.39657437 |
| 129 | NEK2 | 0.38037130 |
| 130 | MAP2K6 | 0.37806575 |
| 131 | MAP3K9 | 0.37647222 |
| 132 | AKT3 | 0.37403392 |
| 133 | MAP2K1 | 0.36938658 |
| 134 | NLK | 0.36904329 |
| 135 | STK39 | 0.36515118 |
| 136 | CDC42BPA | 0.36182903 |
| 137 | CAMK1G | 0.35514062 |
| 138 | FGFR2 | 0.35476884 |
| 139 | GSK3B | 0.34880338 |
| 140 | CAMK2A | 0.34300510 |
| 141 | PDK4 | 0.34275383 |
| 142 | PDK3 | 0.34275383 |
| 143 | MAPK8 | 0.34121824 |
| 144 | MAPK4 | 0.33130894 |
| 145 | PRKACA | 0.32083857 |
| 146 | PDK1 | 0.31328019 |
| 147 | PIK3CA | 0.30836275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GABAergic synapse_Homo sapiens_hsa04727 | 3.08862821 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.00564293 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 2.93733467 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.85575535 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.58564373 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.52875577 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.52866658 |
| 8 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.51286633 |
| 9 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.50693379 |
| 10 | Salivary secretion_Homo sapiens_hsa04970 | 2.48436912 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.32445063 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.26620452 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.24555156 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.22359275 |
| 15 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.20412497 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 2.06005340 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.04391126 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.99291166 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.98941432 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.86958230 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.84354186 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.74091840 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.72620988 |
| 24 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.71811440 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68306201 |
| 26 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.58613132 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58084829 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53732973 |
| 29 | Galactose metabolism_Homo sapiens_hsa00052 | 1.46815264 |
| 30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.43546588 |
| 31 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.40741311 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39431368 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38180744 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.37567508 |
| 35 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.36371919 |
| 36 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.34517399 |
| 37 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.33906526 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.27373199 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26518822 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.26447134 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26376645 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.24894733 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.23876339 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.23506495 |
| 45 | Taste transduction_Homo sapiens_hsa04742 | 1.21675925 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16443396 |
| 47 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14689367 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09233458 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07611278 |
| 50 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.05000374 |
| 51 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.03537543 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.02589376 |
| 53 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.02056132 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99606565 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97446908 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96216641 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.95294108 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93990690 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92539922 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90245742 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89667796 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.88976016 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85256541 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82664061 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81903084 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80758386 |
| 67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78767403 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78719747 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.76584533 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76175814 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73545010 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.71400512 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68933255 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68399544 |
| 75 | Prostate cancer_Homo sapiens_hsa05215 | 0.67111358 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66992970 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65906256 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65641751 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64870469 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58910918 |
| 81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57925865 |
| 82 | Gap junction_Homo sapiens_hsa04540 | 0.57415493 |
| 83 | Tight junction_Homo sapiens_hsa04530 | 0.56693771 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55655298 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.55377305 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54242270 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53213423 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52961731 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51982696 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51859907 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51561426 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49713302 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49057767 |
| 94 | Focal adhesion_Homo sapiens_hsa04510 | 0.48985372 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.47550630 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46413646 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46298694 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.46294750 |
| 99 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45995878 |
| 100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42898954 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41671019 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40356425 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.40258887 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40097872 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.39545682 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39511346 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39323776 |
| 108 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37813962 |
| 109 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36000746 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35245051 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34396582 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30781982 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.30264368 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28923385 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28767187 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27947638 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27598338 |
| 118 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.27500445 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.27055606 |
| 120 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26129832 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.25918992 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.25431614 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25075265 |
| 124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.24933963 |
| 125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.24503817 |
| 126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24132719 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23963770 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.23101054 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22939775 |
| 130 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22048176 |
| 131 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.21568998 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21089937 |
| 133 | Lysine degradation_Homo sapiens_hsa00310 | 0.19895164 |

